Roaa Hadi
Role not yet determined Is this you? Add your title
Also affiliated: University of Maryland, Baltimore County (2024)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Roaa Hadi's research investigates the application of CRISPR-based technologies for COVID-19 diagnosis and therapeutics, and explores the role of biomaterials in enhancing cell therapy. Her work includes optimizing the scalable manufacturing of human mesenchymal stromal cells utilizing bioactive heparin/collagen-coated microcarriers in dynamic culture systems. Additionally, Hadi focuses on the automated deposition of engineered extracellular matrix-like microenvironments for mammalian cell culture. She has authored four publications and has a citation count of 14, with an h-index of 1. Hadi collaborates with researchers at the University of Arkansas at Fayetteville, including Ian Popp, Shilpi Agrawal, Shivakumar Sonnaila, and Venkata Suryanarayana Murthy Bhavaraju.
Metrics
- h-index: 1
- Publications: 5
- Citations: 14
Selected Publications
-
Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers (2026)
-
The Role of Biomaterials in Enhancing Cell Therapy (2026)
-
Optimizing automated layer-by-layer deposition of engineered ECM-like microenvironments for mammalian cell culture (2025)
-
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics (2024)
Collaboration Network
Top Collaborators
- The Role of Biomaterials in Enhancing Cell Therapy
- Optimizing automated layer-by-layer deposition of engineered ECM-like microenvironments for mammalian cell culture
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
- Optimizing automated layer-by-layer deposition of engineered ECM-like microenvironments for mammalian cell culture
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
- The Role of Biomaterials in Enhancing Cell Therapy
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Optimizing automated layer-by-layer deposition of engineered ECM-like microenvironments for mammalian cell culture
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
- Enhancing the Scalable Manufacturing of Human Mesenchymal Stromal Cells in Dynamic Culture Using Bioactive Heparin/Collagen Layer‐by‐Layer Coated Microcarriers
Similar Researchers
Based on overlapping research topics